An update on antifungal susceptibility testing;Actualización en pruebas de susceptibilidad antifúngica

Revista Chilena de Infectologia

Volumn 26, Issue 2, 2009, Pages 144-150

  Tapia P, Cecilia V ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Candida; Casts; Fungal drugs sensitivity tests; Moulds

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; CLASSIFICATION; DRUG EFFECT; FUNGUS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; STANDARD;

ANTIFUNGAL AGENTS; FUNGI; MICROBIAL SENSITIVITY TESTS;

EID: 67651148556     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Richardson M, Lass-Flörl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008; 14 Suppl 4: 5-24.
2. Marr K A, Bowden R A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. White TC. Clin Microbiol Rev 1998; 11: 382-402.
3. Ghannoum M A, Rice L B. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501-17.
4. Forrest G. Role of antifungal susceptibility testing in patient management. Curr Opin Infect Dis 2006; 19: 538-43.
5. Gadea I, Cuenca-Estrella M, Martín E, Pemán J, Pontón J, Rodríguez-Tudela J L. Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing. Enferm Infecc Microbiol Clin 2007; 25: 336-40.
6. Johnson E M. Issues in antifungal susceptibility testing. J Antimicrob Chemother 2008; 61 Suppl 1: i13-8.
7. Rex J H, Pfaller M A, Walsh T J, Chaturvedi V, Espinel-Ingroff A, Ghannoum M A, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001; 14: 643-58.
8. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard NCCLS document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standard; 2002.
9. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard NCCLS document M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards 2002.
10. National Committee for Clinical Laboratory Standards. Methods for antifungal disk diffusion susceptibility testing of yeasts: approved standard M44-A. NCCLS, Wayne, PA, USA, 2004.
11. Arikan S. Current status of antifungal susceptibility testing methods. Med Mycol 2007; 45: 569-87.
12. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Pfaller M A, Rinaldi M, Rodríguez-Tudela J L, et al. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2005; 43: 3884-9.
13. Rodriguez-Tudela J L, Donnelly J P, Pfaller M A, Chryssantou E, Warn P, Denning D W, et al. Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E. Dis. 7.1) and CLSI (M27-A2). J Clin Microbiol 2007; 45: 109-11.
14. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008; 14: 398-405.
15. Antimicrobials for Candida infections-EUCAST clinical MIC breakpoints 2008-07-24 (v 2.0) http://www.srga.org/eucastwt/MICTAB/index.html. (accedido 11 noviembre 2008).
16. Ostrosky-Zeichner L, Rex J H, Pfaller M A, Diekema D J, Alexander B D, Andes D, et al. Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrob Agents Chemother 2008; 52: 4175-7.
17. Pfaller M A, Boyken L B, Hollis R J, Kroeger J, Messer S A, Tendolkar S, et al. Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program. J Clin Microbiol 2008; 46: 3585- 90.
18. Ghannoum M A, Arthington-Skaggs B, Chaturvedi V, Espinel-Ingroff A, Pfaller M A, Rennie R, et al. Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38- A) for testing susceptibilities of dermatophytes to antifungals. J Clin Microbiol 2006; 44: 4353-6.
19. Chryssanthou E, Cuenca-Estrella M. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp. Clin Microbiol Infect 2006; 12: 901-4.
20. Lass-Flörl C, Perkhofer In vitro susceptibility-testing in Aspergillus species. S Mycoses 2008; 51: 437-46.
21. Tapia C, León E, Palavecino E. Antifungal susceptibility of yeasts by Etest. Comparison of 3 media Rev Med Chile 2003; 131: 299-302.
22. Pfaller J B, Messer S A, Hollis R J, Diekema D J, Pfaller M A. In vitro susceptibility testing of Aspergillus spp: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol 2003; 41: 1126-9.
23. Espinel-Ingroff A, Canton E. Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2008; 46: 1793-803.
24. Pfaller M A, Diekema D J, Procop G W, Rinaldi M G. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol 2007; 45: 3522-8.
25. Cuenca-Estrella M, Rodríguez-Tudela J L. Should antifungal treatments be based upon results of antifungal susceptibility testing? Rev Iberoam Micol 2002; 19: 133-8.
26. Gadea I, Cuenca-Estrella M. Infección fúngica invasora (MICOMED); Estudio de la infección en el trasplante (GESITRA); Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SIMC). Guidelines for fungal diagnoses and antifungal sensitivity studies. Enferm Infecc Microbiol Clin 2004; 22: 32-9.
27. Rodríguez-Tudela J L, Díaz-Guerra T M, Mellado E, Cano V, Tapia C, Perkins A, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005; 49: 4026-34.